Blue Owl Capital Holdings »

Waldencast Acquisition Cor A shares owned by Blue Owl Capital Holdings

Quarter-by-quarter ownership of Waldencast Acquisition Cor A (WALDW) shares owned by Blue Owl Capital Holdings from 13F filings

Historical chart of Blue Owl Capital Holdings investment in Waldencast Acquisition Cor A

Tip: Access up to 7 years of quarterly data

All positions including Waldencast Acquisition Cor A held by Blue Owl Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Waldencast Acquisition Cor A by Blue Owl Capital Holdings

Quarter filed Position value Share count Share price at filing
2024-09-30 $5.3k 33k 0.16

More positions owned by Blue Owl Capital Holdings

Nuveen Churchill Direct Lend Com Shs (NCDL)
Klaviyo Com Ser A (KVYO)
Tourmaline Bio (TRML)
Pliant Therapeutics (PLRX)
Cullinan Oncology (CGEM)
Owl Rock Capital Corporation (OBDC)
Larimar Therapeutics (LRMR)
Proshares Tr Ultrapro Qqq (TQQQ)
Engene Holdings (ENGN)
Evercommerce (EVCM)
Acelyrin (SLRN)
Conduent Incorporate (CNDT)
Repare Therapeutics Ord (RPTX)
Context Therapeutics (CNTX)
Ultragenyx Pharmaceutical (RARE)

View all positions for Blue Owl Capital Holdings

Top funds holding Waldencast Acquisition Cor A

Zeno Equity Partners
Highbridge Capital Management
OZ Management
Milestones Administradora de Recursos
JNE Partners
Cowen And Company
Antara Capital
Clear Street
CastleKnight Management
CSS
Saba Capital Management
Atmos Capital Gestao De Recursos
Jane Street
LMR Partners
Truxt Investmentos

View all funds holding Waldencast Acquisition Cor A